Lv32
228 积分 2022-06-29 加入
10 pack-years of smoking: not the magic number for COPD risk and prognosis
1天前
已完结
Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma
3天前
已完结
Perioperative Nivolumab in Resectable Lung Cancer
8天前
已完结
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
10天前
已完结
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
15天前
已完结
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
21天前
已完结
Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer “in a Korean” population: A single-center cohort study
30天前
已完结
Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma
1个月前
已完结
Renal cell carcinoma
1个月前
已完结
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
1个月前
已完结
皖公网安备34019202002308
